semaglutide tablet or injection What to Know About Semaglutide: Oral Tablets vs. Injections Discreet' weight-loss pill is enticing

Most researchers regain 1 to 3 pounds in the first two weeks off (primarily water weight and increased GI contents), then 1 to 2 pounds per month thereafter as appetite normalizes and caloric intake creeps back up

1 Beyond diabetes and obesity Cardiovascular disease In March 2024, the US Food and Drug Administration (FDA) approved Wegovy (semaglutide) for adults with cardiovascular disease (CVD) and either obesity and overweight to reduce the risk of cardiovascular death, heart attack, and stroke

This blog post was written with research and editorial assistance from OnChart

Int J Pharm 618:121637

also listed on the Department of Defense's Prohibited Dietary Supplement Ingredients List Known side effects: In the limited human data available, the most commonly reported adverse effects are mild and transient: injection site redness, swelling, or discomfort, and occasional nausea, fatigue, or headache

If you take other medications that may worsen reflux (such as certain blood pressure medications, bisphosphonates, or NSAIDs), discuss timing strategies with your GP or pharmacist to minimise cumulative effects